Anti-Bet v 1 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-Bet v 1 monoclonal antibody, covering 2024-11-19 to 2024-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants [Phase 2]